Appendix of References with Eligible Data
1.
Alvarez V, Mata IF, Gonzalez P, et al. Association between the TNFalpha308 A/G polymorphism and the onset-age of Alzheimer disease. Am J Med
Genet 2002;114:574-7.
2.
Ardlie KG, Lunetta KL, Seielstad M. Testing for population subdivision and
association in four case-control studies. Am J Hum Genet 2002;71:304-11.
3.
Beranek M, Kankova K, Benes P, et al. Polymorphism R25P in the gene
encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk
factor for proliferative diabetic retinopathy. Am J Med Genet 2002;109:278-83.
4.
Brody LC, Conley M, Cox C, et al. A polymorphism, R653Q, in the
trifunctional enzyme methylenetetrahydrofolate
dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate
synthetase is a maternal genetic risk factor for neural tube defects: report of the
Birth Defects Research Group. Am J Hum Genet 2002;71:1207-15.
5.
Buss S, Muller-Thomsen T, Hock C, et al. No association between DCP1
genotype and late-onset Alzheimer disease. Am J Med Genet 2002;114:440-5.
6.
Casey G, Neville PJ, Plummer SJ, et al. RNASEL Arg462Gln variant is
implicated in up to 13% of prostate cancer cases. Nat Genet 2002;32:581-3.
7.
Cavallini MC, Di Bella D, Siliprandi F, Malchiodi F, Bellodi L. Exploratory
factor analysis of obsessive-compulsive patients and association with 5-HTTLPR
polymorphism. Am J Med Genet 2002;114:347-53.
8.
Chao HM, Richardson MA. Aromatic amino acid hydroxylase genes and
schizophrenia. Am J Med Genet 2002;114:626-30.
9.
Chen AC, Laforge KS, Ho A, et al. Potentially functional polymorphism in the
promoter region of prodynorphin gene may be associated with protection against cocaine
dependence or abuse. Am J Med Genet 2002;114:429-435.
10. Chung IW, Kim H, Lee SI, et al. Evidence for an N-glycosylation
polymorphism of arylsulfatase a predisposing to alcoholism in Koreans. Am J
Med Genet 2002;114:186-9.
11.
Comings DE, Wu S, Rostamkhani M, McGue M, Iacono WG, MacMurray
JP. Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with
major depression in women. Am J Med Genet 2002;114:527-9.
12.
Copin B, Brezin AP, Valtot F, Dascotte JC, Bechetoille A, Garchon HJ.
Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype
of primary open-angle glaucoma and demonstrate interaction with the myocilin
gene. Am J Hum Genet 2002;70:1575-81.
13.
Croen LA, Shaw GM, Barber RC, Baker MM, Finnell RH, Lammer EJ.
Apolipoprotein B and apolipoprotein E genotypes and sporadic holoprosencephaly. Am J
Med Genet 2002;108:75-77.
14.
Cusin C, Serretti A, Lattuada E, Lilli R, Lorenzi C, Smeraldi E. Association
study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness
time course in mood disorders. Am J Med Genet 2002;114:380-90.
15.
Dermaut B, Theuns J, Sleegers K, et al. The gene encoding nicastrin, a
major gamma-secretase component, modifies risk for familial early-onset
Alzheimer disease in a Dutch population-based sample. Am J Hum Genet
2002;70:1568-74.
16.
DeStefano AL, Lew MF, Golbe LI, et al. PARK3 influences age at onset in
Parkinson disease: a genome scan in the GenePD study. Am J Hum Genet
2002;70:1089-95.
17.
Foulkes WD, Thiffault I, Gruber SB, et al. The founder mutation
MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal
cancer in the Ashkenazi Jewish population. Am J Hum Genet 2002;71:1395-412.
18.
Hammond L, Castanotto D, Rice SR, et al. Alteration of branch site
consensus sequence and enhanced pre-mRNA splicing of an NMDAR1 intron
not associated with schizophrenia. Am J Med Genet 2002;114:631-6.
19.
Hassan Z, Mohan V, Ali L, et al. SPINK1 is a susceptibility gene for
fibrocalculous pancreatic diabetes in subjects from the Indian subcontinent. Am J
Hum Genet 2002;71:964-8.
20.
Hattori M, Kunugi H, Akahane A, et al. Novel polymorphisms in the
promoter region of the neurotrophin-3 gene and their associations with
schizophrenia. Am J Med Genet 2002;114:304-9.
21.
Heijmans BT, Slagboom PE, Gussekloo J, et al. Association of APOE
epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not
cardiovascular mortality in old age. Am J Med Genet. 2002;107:201-8.
22.
Imai K, Harada S, Kawanishi Y, Tachikawa H, Okubo T, Asada T.
Association analysis of an (AC)n repeat polymorphism in the GABA(B) receptor
gene and schizophrenia. Am J Med Genet 2002;114:605-8.
23.
Ishiguro H, Okubo Y, Ohtsuki T, Yamakawa-Kobayashi K, Arinami T.
Mutation analysis of the retinoid X receptor beta, nuclear-related receptor 1, and
peroxisome proliferator-activated receptor alpha genes in schizophrenia and
alcohol dependence: possible haplotype association of nuclear-related receptor 1
gene to alcohol dependence. Am J Med Genet 2002;114(1):15-23.
24.
Jahnes E, Muller DJ, Schulze TG, et al. Association study between two
variants in the DOPA decarboxylase gene in bipolar and unipolar affective
disorder. Am J Med Genet 2002;114:519-22.
25.
Kanetsky PA, Swoyer J, Panossian S, Holmes R, Guerry D, Rebbeck TR.
A polymorphism in the agouti signaling protein gene is associated with human
pigmentation. Am J Hum Genet 2002;70:770-5.
26.
Li T, Liu X, Zhao J, et al. Allelic association analysis of the dopamine D2,
D3, 5-HT2A, and GABA(A)gamma2 receptors and serotonin transporter genes
with heroin abuse in Chinese subjects. Am J Med Genet 2002;114:329-35.
27.
Liede A, Malik IA, Aziz Z, Rios Pd Pde L, Kwan E, Narod SA. Contribution
of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J
Hum Genet 2002;71:595-606.
28.
Limosin F, Gorwood P, Loze JY, et al. Male limited association of the
dopamine receptor D2 gene TaqI a polymorphism and alcohol dependence. Am
J Med Genet 2002;112:343-6.
29.
Lin RC, Morris BJ. Association analysis of polymorphisms at the
interleukin-1 locus in essential hypertension. Am J Med Genet 2002;107:311-6.
30.
Marti SB, Cichon S, Propping P, Nothen M. Metabotropic glutamate
receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar
affective disorder in the German population. Am J Med Genet 2002;114:46-50.
31.
Mateo I, Sanchez-Guerra M, Combarros O, et al. Lack of association
between cathepsin D genetic polymorphism and Alzheimer disease in a Spanish
sample. Am J Med Genet 2002;114:31-3.
32.
Muller DJ, Schulze TG, Jahnes E, et al. Association between a
polymorphism in the pseudoautosomal X-linked gene SYBL1 and bipolar
affective disorder. Am J Med Genet 2002;114:74-8.
33.
Niimi T, Munakata M, Keck-Waggoner CL, et al. A polymorphism in the
human UGRP1 gene promoter that regulates transcription is associated with an
increased risk of asthma. Am J Hum Genet 2002;70:718-25.
34.
Nishiguchi N, Shirakawa O, Ono H, et al. Lack of an association between
5-HT1A receptor gene structural polymorphisms and suicide victims. Am J Med
Genet 2002;114:423-5.
35.
Norton N, Kirov G, Zammit S, et al. Schizophrenia and functional
polymorphisms in the MAOA and COMT genes: no evidence for association or
epistasis. Am J Med Genet 2002;114:491-6.
36.
O'Leary VB, Parle-McDermott A, Molloy AM, et al. MTRR and MTHFR
polymorphism: link to Down syndrome? Am J Med Genet 2002;107:151-5.
37.
Ono H, Shirakawa O, Nishiguchi N, et al. No evidence of an association
between a functional monoamine oxidase a gene polymorphism and completed
suicides. Am J Med Genet 2002;114:340-2.
38.
Ozaki K, Ohnishi Y, Iida A, et al. Functional SNPs in the lymphotoxinalpha gene that are associated with susceptibility to myocardial infarction. Nat
Genet 2002;32:650-4.
39.
Poduslo SE, Shook B, Drigalenko E, Yin X. Lack of association of the two
polymorphisms in alpha-2 macroglobulin with Alzheimer disease. Am J Med
Genet 2002;110:30-5.
40.
Rennert H, Bercovich D, Hubert A, et al. A novel founder mutation in the
RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi
Jews. Am J Hum Genet 2002;71:981-4.
41.
Rokman A, Ikonen T, Seppala EH, et al. Germline alterations of the
RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with
prostate cancer. Am J Hum Genet 2002;70:1299-304.
42.
Roks G, Cruts M, Houwing-Duistermaat JJ, et al. Effect of the APOE491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer
disease: The Rotterdam Study. Am J Med Genet 2002;114:570-3.
43.
Sand PG, Schlurmann K, Luckhaus C, et al. Estrogen receptor 1 gene
(ESR1) variants in panic disorder. Am J Med Genet 2002;114:426-8.
44.
Segman RH, Shapira Y, Modai I, et al. Angiotensin converting enzyme
gene insertion/deletion polymorphism: case-control association studies in
schizophrenia, major affective disorder, and tardive dyskinesia and a familybased association study in schizophrenia. Am J Med Genet 2002;114:310-4.
45.
Serretti A, Lorenzi C, Lilli R, Mandelli L, Pirovano A, Smeraldi E.
Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT,
MAO-A, and Gbeta3 variants. Am J Med Genet 2002;114:370-9.
46.
Shaw GM, Lammer EJ, Zhu H, Baker MW, Neri E, Finnell RH. Maternal
periconceptional vitamin use, genetic variation of infant reduced folate carrier
(A80G), and risk of spina bifida. Am J Med Genet 2002;108:1-6.
47.
Shibata N, Ohnuma T, Takahashi T, et al. Effect of IL-6 polymorphism on risk of
Alzheimer disease: genotype-phenotype association study in Japanese cases. Am J Med
Genet. 2002;114:436-439.
48.
Shifman S, Bronstein M, Sternfeld M, et al. A highly significant association
between a COMT haplotype and schizophrenia. Am J Hum Genet 2002;71:1296302.
49.
Staner L, Uyanik G, Correa H, et al. A dimensional impulsive-aggressive
phenotype is associated with the A218C polymorphism of the tryptophan
hydroxylase gene: a pilot study in well-characterized impulsive inpatients. Am J
Med Genet 2002;114:553-7.
50.
Takei T, Iida A, Nitta K, et al. Association between single-nucleotide
polymorphisms in selectin genes and immunoglobulin A nephropathy. Am J Hum
Genet 2002;70:781-6.
51.
Tan EC, Chong SA, Chan AO, Tan CH. No evidence for association of the
T102C polymorphism in the serotonin type 2A receptor with suicidal behavior in
schizophrenia. Am J Med Genet 2002;114:321-2.
52.
Tang G, Xie H, Xu L, Hao Y, Lin D, Ren D. Genetic study of
apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson
disease. Am J Med Genet. 2002;114:446-449.
53.
Toyota T, Hattori E, Meerabux J, et al. Molecular analysis, mutation
screening, and association study of adenylate cyclase type 9 gene (ADCY9) in
mood disorders. Am J Med Genet 2002;114:84-92.
54.
Tsai MT, Hung CC, Tsai CY, et al. Mutation analysis of synapsin III gene
in schizophrenia. Am J Med Genet 2002;114:79-83.
55.
Vahteristo P, Bartkova J, Eerola H, et al. A CHEK2 genetic variant
contributing to a substantial fraction of familial breast cancer. Am J Hum Genet
2002;71:432-8.
56.
Villafuerte SM, Del-Favero J, Adolfsson R, et al. Gene-based SNP genetic
association study of the corticotropin-releasing hormone receptor-2 (CRHR2) in
major depression. Am J Med Genet 2002;114(2):222-6.
57.
Wang L, McDonnell SK, Elkins DA, et al. Analysis of the RNASEL gene in
familial and sporadic prostate cancer. Am J Hum Genet 2002;71:116-23.
58.
Wang Z, Wassink T, Andreasen NC, Crowe RR. Possible association of a
cholecystokinin promoter variant to schizophrenia. Am J Med Genet
2002;114:479-82.
59.
Xu K, Liu XH, Nagarajan S, Gu XY, Goldman D. Relationship of the deltaopioid receptor gene to heroin abuse in a large Chinese case/control sample. Am
J Med Genet 2002;110:45-50.
60.
Yu CE, Dawson G, Munson J, et al. Presence of large deletions in
kindreds with autism. Am J Hum Genet 2002;71:100-15.
61.
Zill P, Baghai TC, Zwanzger P, et al. Association analysis of a
polymorphism in the G-protein stimulatory alpha subunit in patients with major
depression. Am J Med Genet 2002;114:530-2.